Shanghai TheraMabs Bio-technology co., LTD
We are professional supplier in antibodies and fusion proteins,such as Pembrolizumab, Nivolumab, Transtuzumab,etc.
Business Type:Manufacturer
Country/Region:China
Ddu Verified
HOT Rank
Purchase
Description
STELARA® (Ustekinumab) is a human IgG1κ monoclonal antibody against the p40 subunit of the IL-12 and IL-23 cytokines. Using DNA recombinant technology, ustekinumab is produced in a well characterized recombinant cell line and is purified using standard bio-processing technology. The manufacturing process contains steps for the clearance of viruses. Ustekinumab is comprised of 1326 amino acids and has an estimated molecular mass that ranges from 148,079 to 149,690 Daltons.
Ustekinumab is a sterile, preservative-free, colorless to light yellow solution and may contain a few small translucent or white particles with pH of 5.7- 6.3. Ustekinumab is supplied at a concentration of 5 mg/mL, which contains 0.02 mg/mL EDTA disodium salt dihydrate, 0.77 mg/mL L-histidine, 1.04 mg/mL L-histidine hydrochloride monohydrate, 0.4 mg/mL L-methionine, 0.4 mg/mL Polysorbate 80 and 85 mg/mL sucrose.
Properties
Name | Ustekinumab |
CAS NO. | 815610-63-0 |
Type | Whole antibody |
Source | Human |
Target | IL-12 and IL-23 |
Clone | Monoclone |
Molecular Weight | 148 kDa |
Formula | C6482H10004N1712O2016S46 |
Antibody Form | Purified immunoglobulin |
Physical Form | Solution |
Grade Standard | Medicine Grade |
Place of Origin | China (Mainland) |
Storage | -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Supply Ability
20 kilogram per year, 1 Gram（Min. Order）.
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
If you need more information, please contact us.
Detail information about the product please refer the website below:
https://en.wikipedia.org/wiki/Ustekinumab
